最新的进展:改善PEEK材料的抗炎和免疫调节特性
Zilin Zhang1,2, Xingmin Zhang1,2, Zhi Zheng1,2
1Department of Spine Surgery, Center of Orthopedics, First Hospital of Jilin University, Changchun, 130021, China.
Materials today. Bio
|August 21, 2023
概括
聚乙基 (PEEK) 对骨科植入物有希望,但其惰性导致免疫反应和纤维囊形成. 正在开发修改以增强PEEK的功能.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 整形外科手术 整形外科手术
背景情况:
- 聚乙基 (PEEK) 为骨科植入物提供了出色的生物相容性和机械性能.
- 然而,PEEK的生物惰性可以引发不良的免疫反应,导致纤维状囊的形成和潜在的植入失败.
- 目前的研究往往侧重于骨质生成和抗菌性质,忽视了PEEK的免疫调节能力.
研究的目的:
- 总结了将PEEK植入与纤维囊形成联系在一起的机制.
- 审查旨在改善PEEK抗炎和免疫调节能力的修改技术.
- 讨论基于PEEK的骨科材料的局限性和未来前景.
主要方法:
- 对PEEK免疫调节研究的文献综述.
- 对PEEK植入物免疫反应的潜在机制的分析.
- 评估各种PEEK修饰策略 (药物输送,表面修饰,多孔性处理).
主要成果:
- 皮克的惰性会引起免疫反应,阻碍骨的整合,促进纤维组织的增殖.
- 修改技术,如药物输送,表面化学和多孔结构可以调节免疫反应.
- 这些策略旨在减轻炎症并改善PEEK的生物活性,以获得更好的临床结果.
结论:
- 调节免疫反应对于克服PEEK的生物惰性至关重要.
- 先进的修饰技术为开发下一代PEEK整形植入物提供了有希望的途径.
- 需要进一步的研究才能充分理解和利用PEEK的免疫调节潜力.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
495
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
495
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173


